| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 97.329 | 91.873 | 87.943 | 60.648 | 53.793 | 121.176 | 271.799 | 202.455 | 228.978 | 210.808 |
| Total Income - EUR | 100.097 | 94.182 | 107.647 | 60.649 | 79.082 | 122.119 | 273.990 | 202.781 | 229.104 | 210.943 |
| Total Expenses - EUR | 98.089 | 80.141 | 80.260 | 69.294 | 89.032 | 81.795 | 179.310 | 178.025 | 165.359 | 162.094 |
| Gross Profit/Loss - EUR | 2.009 | 14.040 | 27.387 | -8.645 | -9.950 | 40.324 | 94.680 | 24.756 | 63.745 | 48.848 |
| Net Profit/Loss - EUR | 412 | 11.376 | 24.237 | -9.247 | -10.665 | 39.148 | 92.109 | 22.520 | 62.222 | 42.520 |
| Employees | 9 | 15 | 11 | 3 | 3 | 3 | 3 | 3 | 3 | 2 |
Check the financial reports for the company - Olgamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 93.008 | 82.105 | 74.719 | 70.798 | 36.434 | 32.373 | 29.073 | 52.012 | 42.013 | 30.518 |
| Current Assets | 13.375 | 33.556 | 46.717 | 35.339 | 28.533 | 62.832 | 150.258 | 67.939 | 84.333 | 76.891 |
| Inventories | 185 | 0 | 0 | 0 | 572 | 5.354 | 11.681 | 10.623 | 2.424 | 2.401 |
| Receivables | 11.818 | 6.699 | 9.553 | 14.827 | 11.218 | 6.887 | 15.959 | 50.478 | 74.724 | 68.267 |
| Cash | 1.371 | 26.857 | 37.164 | 20.512 | 16.743 | 50.590 | 122.618 | 6.838 | 7.185 | 6.223 |
| Shareholders Funds | 21.167 | 32.895 | 56.576 | 46.291 | 34.729 | 73.218 | 163.704 | 89.283 | 83.577 | 95.611 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 85.216 | 82.767 | 64.860 | 59.847 | 30.238 | 21.987 | 15.628 | 30.668 | 42.769 | 11.797 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Olgamed Srl